Both in Pharmaceuticals
Lite Strategy vs Biote
Over the past year LITS returned −36.3% and BTMD returned −58.0%; their daily moves had a correlation of 0.01.
LITS −36.3% BTMD −58.0%Growth of $1, one year, split-adjusted
| Metric | LITS | BTMD |
|---|---|---|
| Price | $1.23 | $1.15 |
| Market cap | $37.4M | $33.0M |
| Today | +6.49% | −2.54% |
| 1 month | −10.5% | −7.3% |
| 6 months | +7.0% | −48.2% |
| Year to date | −6.8% | −55.8% |
| 1 year | −41.1% | −60.3% |
| Revenue growth (YoY) | — | −9.5% |
| Gross margin | — | 65.4% |
| Net margin | — | −14.8% |
| P/E (TTM) | — | 5.6× |
| Price / sales | — | 0.2× |
| Net cash | $5.7M | -$110.3M |
| Dividend yield | — | — |
| Volatility (60d) | 78.5% | 94.8% |
| Short % of float | 0.4% | 5.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).